ArticleThe Lancet. Oncology2022
ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma.
Marjorie G Zauderer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2022
Marjorie G Zauderer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.